Thilo Hackert Selected Research

Biomarkers (Surrogate Marker)

5/2021	Blood biomarkers for differential diagnosis and early detection of pancreatic cancer.
1/2021	Assessment of tissue perfusion of pancreatic cancer as potential imaging biomarker by means of Intravoxel incoherent motion MRI and CT perfusion: correlation with histological microvessel density as ground truth.
1/2021	Peripheral blood and tissue assessment highlights differential tumor-circulatory gradients of IL2 and MIF with prognostic significance in resectable pancreatic ductal adenocarcinoma.
1/2021	Noninvasive Discrimination of Low and High-risk Pancreatic Intraductal Papillary Mucinous Neoplasms.
1/2021	Epithelial-to-Mesenchymal Transition in Pancreatic Cancer is associated with Restricted Water Diffusion in Diffusion-Weighted Magnetic Resonance Imaging.
12/2020	Restricted Water Diffusion in Diffusion-Weighted Magnetic Resonance Imaging in Pancreatic Cancer is Associated with Tumor Hypoxia.
1/2020	Actinin-4 splice variant - a complementary diagnostic and prognostic marker of pancreatic neuroendocrine neoplasms.
1/2020	SST gene hypermethylation acts as a pan-cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood-based diagnosis.
10/2019	Cachectic Body Composition and Inflammatory Markers Portend a Poor Prognosis in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiation.
1/2019	Distinct Origin of Claudin7 in Early Tumor Endosomes Affects Exosome Assembly.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thilo Hackert Research Topics

Disease

99	Neoplasms (Cancer) 07/2022 - 01/2008
86	Pancreatic Neoplasms (Pancreatic Cancer) 12/2022 - 01/2008
33	Adenocarcinoma 01/2022 - 01/2008
24	Pancreatic Fistula (Pancreatic Fistulas) 07/2022 - 05/2010
23	Pancreatitis 04/2022 - 01/2003
14	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2016
11	Inflammation (Inflammations) 01/2022 - 02/2004
10	Chronic Pancreatitis 06/2020 - 09/2005
7	Sepsis (Septicemia) 01/2022 - 01/2003
6	Hemorrhage 07/2022 - 09/2007
6	Necrosis 05/2017 - 03/2006
5	Fistula 07/2022 - 08/2006
5	Ischemia 01/2022 - 03/2006
5	Margins of Excision 01/2021 - 08/2008
4	Acute Necrotizing Pancreatitis 07/2022 - 04/2006
4	Wounds and Injuries (Trauma) 12/2021 - 10/2015
4	Anastomotic Leak 11/2021 - 08/2008
4	Cachexia 01/2020 - 09/2012
3	Hyperemia 12/2022 - 10/2021
3	Surgical Wound Infection 06/2022 - 07/2014
3	Hyperamylasemia 04/2022 - 01/2021
3	Neoplasms, Cystic, Mucinous, and Serous 01/2022 - 01/2016
3	Body Weight (Weight, Body) 01/2022 - 01/2019
3	Fibrosis (Cirrhosis) 01/2022 - 11/2006
3	Lymphatic Metastasis 03/2021 - 05/2017
3	Disease Progression 01/2019 - 07/2010
3	Edema (Dropsy) 10/2017 - 02/2004
2	Carcinoma (Carcinomatosis) 01/2022 - 05/2018
2	Obesity 01/2022 - 09/2012
2	Head and Neck Neoplasms (Head and Neck Cancer) 11/2021 - 01/2021
2	Carcinogenesis 10/2021 - 01/2018
2	Septic Shock (Toxic Shock Syndrome) 06/2021 - 01/2019
2	Diabetes Mellitus 06/2020 - 01/2020
2	Peritonitis 01/2020 - 01/2017
2	Sarcopenia 10/2019 - 05/2019
2	Weight Loss (Weight Reduction) 10/2019 - 05/2019
2	Breast Neoplasms (Breast Cancer) 06/2019 - 04/2005
2	Colonic Neoplasms (Colon Cancer) 01/2019 - 02/2016
2	Cysts 01/2019 - 11/2015

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 05/2021 - 07/2016
11	Gemcitabine FDA Link 11/2021 - 06/2012
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2008
8	Amylases FDA Link 01/2021 - 02/2004
7	folfirinoxIBA 10/2021 - 01/2016
7	CeruletideIBA 03/2012 - 02/2004
6	CytokinesIBA 01/2022 - 08/2009
5	Pharmaceutical PreparationsIBA 01/2020 - 03/2016
5	Glycodeoxycholic AcidIBA 01/2014 - 02/2004
4	C-Reactive ProteinIBA 12/2022 - 07/2019
4	Messenger RNA (mRNA)IBA 11/2021 - 01/2008
4	Fluorouracil (Carac)FDA LinkGeneric 11/2021 - 11/2017
4	MicroRNAs (MicroRNA)IBA 01/2021 - 09/2011
3	CarbohydratesIBA 12/2022 - 07/2013
3	AntigensIBA 12/2022 - 07/2013
3	Leucovorin (Folinic Acid)FDA Link 11/2020 - 11/2017
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2020 - 03/2019
3	TetraspaninsIBA 01/2020 - 02/2018
3	Tumor Biomarkers (Tumor Markers)IBA 01/2020 - 07/2013
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 02/2015
3	LigandsIBA 01/2019 - 02/2016
3	Peptide Hydrolases (Proteases)FDA Link 02/2018 - 08/2016
3	Peroxidase (Myeloperoxidase)IBA 01/2014 - 09/2008
2	AlbuminsIBA 12/2022 - 12/2020
2	N-acetyltalosaminuronic acid (NAT)IBA 07/2022 - 01/2021
2	Indicators and Reagents (Reagents)IBA 04/2022 - 01/2020
2	Interleukin-2 (IL2)IBA 01/2022 - 01/2021
2	CollagenIBA 07/2021 - 06/2007
2	InterferonsIBA 01/2021 - 01/2008
2	Transcription Factors (Transcription Factor)IBA 12/2020 - 05/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2020 - 01/2008
2	Irinotecan (Camptosar)FDA LinkGeneric 11/2020 - 03/2019
2	interleukin-21 (interleukin 21)IBA 01/2020 - 01/2019
2	InterleukinsIBA 01/2020 - 01/2019
2	Ataxin-10IBA 01/2020 - 02/2016
2	GlucocorticoidsIBA 01/2020 - 10/2017
2	Botulinum Toxins (Botulinum Toxin)IBA 01/2020 - 01/2017
2	ChemokinesIBA 01/2020 - 02/2016
2	Interleukin-6 (Interleukin 6)IBA 07/2019 - 09/2007
2	ErbB Receptors (EGF Receptor)IBA 06/2019 - 01/2018
2	Capecitabine (Xeloda)FDA Link 03/2019 - 11/2017

Therapy/Procedure

44	Therapeutics 01/2022 - 08/2006
27	Pancreatectomy 12/2022 - 05/2010
27	Drug Therapy (Chemotherapy) 06/2022 - 04/2005
23	Neoadjuvant Therapy 07/2022 - 08/2008
21	Pancreaticoduodenectomy 01/2022 - 12/2011
9	Length of Stay 06/2022 - 08/2008
8	Adjuvant Chemotherapy 01/2022 - 03/2012
5	Operative Surgical Procedures 01/2021 - 08/2011
4	Resistance Training 01/2022 - 01/2019
4	Splenectomy 10/2021 - 01/2011
4	Lymph Node Excision (Lymph Node Dissection) 03/2021 - 08/2008
3	Stents 11/2021 - 10/2015
3	Immunotherapy 08/2021 - 01/2017
3	Combined Modality Therapy 04/2020 - 03/2013
3	Laparotomy 01/2020 - 09/2007
3	Pancreas Transplantation 11/2014 - 01/2005
2	Conservative Treatment 01/2022 - 05/2021
2	Ligation 11/2021 - 09/2007
2	Transplantation 03/2020 - 11/2006
2	Induction Chemotherapy 01/2020 - 07/2019